NASDAQ · Biotechnology

Fennec Pharmaceuticals Inc. (FENC) Stock

$10.69 +0.56% NASDAQ: FENC Healthcare

Valuation

MetricValue
Price$10.69
Market Cap$371.34M
P/E Ratio-78.46
P/B Ratio8.30
P/S Ratio5.98
EPS (TTM)$-0.36
52-Week High$13.25
52-Week Low$5.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-11.71%
ROA-4.29%
ROCE-1.84%
Gross Margin-13.33%
Operating Margin-13.33%
Net Margin-5.49%
Debt/Equity0.00
Current Ratio6.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$2.0M$21.0M$48.0M$45.0M
Operating Profit$-17.0M$-23.0M$-13.0M$2.0M$-6.0M
Net Profit$-17.0M$-24.0M$-16.0M$0$-10.0M
EPS$-0.67$-0.95$-0.60$-0.02$-0.36
Op Margin—-1481.3%-61.4%5.2%-14.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$27.0M$27.0M$45.0M$70.0M
Total Liabilities$7.0M$30.0M$38.0M$51.0M$35.0M
Cash$21.0M$24.0M$13.0M$27.0M$37.0M
Borrowings$5.0M$25.0M$31.0M$19.0M$0

Latest News

Is the Options Market Predicting a Spike in Adherex Technologies Stock? Zacks · Jul 6, 2026 Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire · Jun 22, 2026 Fennec Announces Results of Annual Meeting GlobeNewswire · Jun 10, 2026 Insider Favorites High Growth Companies June 2026 Simply Wall St. · Jun 8, 2026 Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter MarketBeat · May 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-18.0M$-17.0M$27.0M$-12.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$1.0M$2.0M$-1.0M$-3.0M
Net Cash Flow$-9.0M$3.0M$-11.0M$13.0M$10.0M
Free Cash Flow$-14.0M$-18.0M$-17.0M$27.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.40
EV / EBITDA-131.76
FCF Yield-0.58%
Quick Ratio5.66
Interest Coverage-1.29
Return 1Y16.27%
Return 3Y25.00%
Return 5Y68.84%

Ownership

Insiders Held14.46%
Institutions Held54.31%
Institutions Float Held63.49%
Institutional HolderSharesReport Date
Rosalind Advisors, Inc.2,908,2012026-03-31
Southpoint Capital Advisors Lp2,744,7412026-03-31
Solas Capital Management, LLC2,482,1982026-03-31
AIGH Capital Management LLC1,981,5012026-03-31
Blackrock Inc.1,368,1762026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AARDAardvark Therapeutics, Inc. $4.69 -0.42% -1.55 $102.64M 0.00%
AVTXAvalo Therapeutics, Inc. $13.68 +1.86% -3.16 $719.10M 0.00%
BDTXBlack Diamond Therapeutics, Inc. $1.81 -1.09% -2.62 $103.72M 0.00%
CRBUCaribou Biosciences, Inc. $0.49 +1.21% -1.13 $48.30M 0.00%
ENTAEnanta Pharmaceuticals, Inc. $12.15 +0.44% -5.32 $353.40M 0.00%

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. is led by CEO Jeffrey S. Hackman, employs 32 people, headquartered in US, publicly traded since 2017.

Fennec Pharmaceuticals Inc. (FENC) stock trades at $10.69 with a market capitalization of $371.34M. The stock is valued at a price-to-earnings (P/E) ratio of -78.46, price-to-book of 8.30, price-to-sales of 5.98. Over the past 52 weeks the stock has ranged between $5.65 and $13.25, and currently trades 19.3% below its 52-week high.

On profitability, Fennec Pharmaceuticals Inc. generates a return on equity (ROE) of -11.71%, return on capital employed of -1.84%, an operating margin of -13.33%, a net profit margin of -5.49%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1178.88 +0.79% JNJ Johnson & Johnson $260.66 +1.63% ABBV AbbVie Inc. $277.31 +1.80% MRK Merck & Company, Inc. Common Stock (new) $145.34 +2.08% UNH UnitedHealth Group Incorporated Common Stock (DE) $376.24 +1.43% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $658.31 +0.97% AMGN Amgen Inc. $413.31 +1.44% GILD Gilead Sciences, Inc. $151.18 +2.77% ABT Abbott Laboratories $99.69 +1.21% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides